- Home
- HUMAW vs CENX Comparison
HUMAW vs CENX Comparison
Compare HUMAW & CENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMAW
- CENX
- Stock Information
- Founded
- HUMAW N/A
- CENX 1995
- Country
- HUMAW United States
- CENX United States
- Employees
- HUMAW 185
- CENX N/A
- Industry
- HUMAW Biotechnology: Pharmaceutical Preparations
- CENX Aluminum
- Sector
- HUMAW Health Care
- CENX Industrials
- Exchange
- HUMAW Nasdaq
- CENX Nasdaq
- Market Cap
- HUMAW N/A
- CENX N/A
- IPO Year
- HUMAW 2020
- CENX 1996
- Fundamental
- Price
- HUMAW $1.74
- CENX $18.33
- Analyst Decision
- HUMAW
- CENX Buy
- Analyst Count
- HUMAW 0
- CENX 3
- Target Price
- HUMAW N/A
- CENX $21.00
- AVG Volume (30 Days)
- HUMAW N/A
- CENX 1.0M
- Earning Date
- HUMAW N/A
- CENX 11-04-2024
- Dividend Yield
- HUMAW N/A
- CENX N/A
- EPS Growth
- HUMAW N/A
- CENX N/A
- EPS
- HUMAW N/A
- CENX 3.19
- Revenue
- HUMAW N/A
- CENX $2,101,699,999.00
- Revenue This Year
- HUMAW N/A
- CENX N/A
- Revenue Next Year
- HUMAW N/A
- CENX $12.05
- P/E Ratio
- HUMAW N/A
- CENX $5.75
- Revenue Growth
- HUMAW N/A
- CENX N/A
- 52 Week Low
- HUMAW N/A
- CENX $9.65
- 52 Week High
- HUMAW N/A
- CENX $25.39
- Technical
- Relative Strength Index (RSI)
- HUMAW N/A
- CENX 31.86
- Support Level
- HUMAW N/A
- CENX $23.25
- Resistance Level
- HUMAW N/A
- CENX $24.22
- Average True Range (ATR)
- HUMAW 0.00
- CENX 1.14
- MACD
- HUMAW 0.00
- CENX -0.68
- Stochastic Oscillator
- HUMAW 0.00
- CENX 8.67
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.